Ulrich R. Abel
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Investigation of the GnRH antagonist degarelix isomerization in biological matrices.
Journal: Pharmacology research & perspectives
Published: June 22, 2023
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial.
Journal: British journal of cancer
Published: February 08, 2018
Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions-A calibration approach.
Journal: Biometrical journal. Biometrische Zeitschrift
Published: October 25, 2017
Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts.
Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts.
Journal: EMBO molecular medicine
Published: May 21, 2017
Synthesis of 3,4-dihydro-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxides and their evaluation as ligands for NMDA receptor glycine binding site.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 27, 2015
Some Issues of Sample Size Calculation for Time-to-Event Endpoints Using the Freedman and Schoenfeld Formulas.
Journal: Journal of biopharmaceutical statistics
Published: January 29, 2015
Chemotherapy for advanced pancreatic adenocarcinoma in elderly patients (≥70 years of age): a retrospective cohort study at the National Center for Tumor Diseases Heidelberg.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: October 23, 2013
Exercise in patients with non-small cell lung cancer.
Journal: Medicine and science in sports and exercise
Published: September 18, 2013
Scaffold hopping approach towards various AFQ-056 analogs as potent metabotropic glutamate receptor 5 negative allosteric modulators.
Journal: Bioorganic & medicinal chemistry letters
Published: August 19, 2013
Discovery, synthesis, and structure-activity relationships of 2-aminoquinazoline derivatives as a novel class of metabotropic glutamate receptor 5 negative allosteric modulators.
Journal: Bioorganic & medicinal chemistry letters
Published: May 14, 2013
Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 26, 2012
Last Updated: 09/26/2026